6-minute Stepper Test and Pulmonary Rehabilitation in Patients With Chronicle Obstructive Pulmonary Disease
6STaR
Use of the 6-minute Stepper Test to Individualise Pulmonary Rehabilitation in Patients With Mild to Moderate Chronicle Obstructive Pulmonary Disease
1 other identifier
observational
105
1 country
4
Brief Summary
The purpose of this study is to determine, if it exists, a relation between plateau heart rate from the last 3 minutes of the 6-minute stepper test and heart rate from first ventilatory threshold from cardiopulmonary exercise testing in order to individualise pulmonary rehabilitation in patients with mild to moderate chronicle obstructive pulmonary disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2016
Longer than P75 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2016
CompletedFirst Submitted
Initial submission to the registry
July 19, 2016
CompletedFirst Posted
Study publicly available on registry
July 25, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2023
CompletedMarch 21, 2024
March 1, 2024
7.4 years
July 19, 2016
March 20, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
Relation between plateau heart rate (bpm) from the first and last 3 minutes of the 6-minute stepper test and heart rate (bpm) from first ventilatory threshold from cardiopulmonary exercise testing.
Outcome (heart rate) during different tests will be continuously recorded. Relation will be adjusted for age and step count.
Heart rate (bpm) will be assessed during cardiopulmonary exercise testing with electrocardiogram. During the 2 6-minute stepper test, heart will be assessed with oximeter. All theses tests wil be carried out in a total time frame of 3 month maximum.
Secondary Outcomes (3)
Relation between minimal SpO2 (%)from the 6-minute stepper test and SpO2 (%) from first ventilatory threshold from cardiopulmonary exercise testing.
SpO2 will be assessed with oximeter. All theses tests wil be carried out in a total time frame of 3 month maximum.
Blood pressure (mmHg) before and after every 6-minute stepper test using electrical blood pressure device.
The outcome will be assessed before and after every 6-minute stepper test. The 2 6-minute stepper test will be carried out the same day (minimum 20 minute of rest between each test) for a total time frame of 1 day.
Steps during 6-minute stepper test using stepper device.
The 2 6-minute stepper test will be carried out on the same day (20 minute of rest between each test) for a total time frame of 1 day.
Study Arms (1)
Prospective observational cohort
Every patient referred to pulmonary rehabilitation program will be eligible. They will perform cardiopulmonary exercise testing prior to join rehabilitation program. During the first session of pulmonary rehabilitation, they will perform 2 6-minute stepper test with a rest of 20 minutes minimum between each test.
Interventions
Eligibility Criteria
Patients with chronicle obstructive pulmonary disease reffered for pulmonary rehabilitation.
You may qualify if:
- Age \> 18 ans ;
- Chronicle obstructive pulmonary disease stage I/II (FEV1 ≥ 50%) ;
- Chronicle obstructive pulmonary disease stage III/IV (FEV1 \< 50%) from may 2019 (ethical approvement granted)
- Weight ≤ 90kg ;
- Eligible for pulmonary rehabilitation.
You may not qualify if:
- Pregnant woman or likely to be ;
- Patient under guardianship ;
- Contraindication to cardiopulmonary exercise testing ;
- Patient medically treated with heart rate modulator (excluding oral B2-agonist) ;
- Patient treated with pacemaker or defibrillator ;
- History of lower limb impairment (i.e. peripheral artery disease, orthopedic disorder etc.).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- ADIR Associationlead
Study Sites (4)
ADIR Association
Bois-Guillaume, France
Centre Hostalier Intercommunal Elbeuf-Louviers-Val de Reuil
Elbeuf, France
Groupe Hospitalier du Havre
Le Havre, France
Centre Hospitalier de Morlaix
Morlaix, France
Related Publications (1)
Bonnevie T, Clet A, Beaumont M, Smondack P, Combret Y, Medrinal C, Prieur G, Boujibar F, Muir JF, Cuvelier A, Grosbois JM, Debeaumont D, Artaud-Macari E, Gravier FE. Estimating endurance training intensity prescription from the 6-minute stepper test in people with chronic obstructive pulmonary disease - a multicenter cross-sectional study with external validation. Pulmonology. 2025 Dec 31;31(1):2486875. doi: 10.1080/25310429.2025.2486875. Epub 2025 Apr 11.
PMID: 40211884DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
David Debeaumont, MD
CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de physiologie urinaire, digestive, respiratoire et sportive, Bois-Guillaume, France
- STUDY CHAIR
Catherine Tardif, MD
CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de physiologie urinaire, digestive, respiratoire et sportive, Bois-Guillaume, France
- STUDY CHAIR
Antoine Cuvelier, Prof, PhD
CHU-Hôpitaux de Rouen - Service de pneumologie, Hôpital de Bois-Guillaume, Rouen, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France.
- STUDY CHAIR
Tristan Bonnevie, MsC
ADIR Association, Bois-Guillaume, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France
- STUDY CHAIR
Francis-Edouard Gravier, PT
ADIR Association, Bois-Guillaume, France
- STUDY CHAIR
Catherine Viacroze, MD
CHU-Hôpitaux de Rouen - Hôpital de Bois-Guillaume, Service de pneumologie, Bois-Guillaume, France
- STUDY CHAIR
Jean-François Muir, Prof, PhD
CHU-Hôpitaux de Rouen - Service de pneumologie, Hôpital de Bois-Guillaume, Rouen, France ; UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France ; ADIR Association, Bois-Guillaume, France
- STUDY CHAIR
Bouchra Lamia, Prof, PhD
UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France ; Service de pneumologie, Hôpital Jacques Monod 76290 Montivilliers
- STUDY CHAIR
Jean Quieffin, MD
Service de pneumologie, Hôpital Jacques Monod 76290 Montivilliers
- STUDY CHAIR
Guillaume Prieur, PT, MsC
Service de pneumologie, Hôpital Jacques Monod 76290 Montivilliers
- STUDY CHAIR
Clément Médrinal, PT, MsC
UPRES EA 3830, Institut de Recherche et d'Innovation Biomédicale de Haute-Normandie, Université de Rouen, Rouen, France. Service de réanimation, Groupe Hospitalier du Havre, France
- STUDY CHAIR
Pierre-Alexandre Hauss, MD
Service de pneumologie, Centre Hosptalier Intercommunal Elbeuf-Louviers-Val de Reuil
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 19, 2016
First Posted
July 25, 2016
Study Start
July 1, 2016
Primary Completion
December 1, 2023
Study Completion
December 1, 2023
Last Updated
March 21, 2024
Record last verified: 2024-03